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Background: Cardiovascular disease prevention is guided by so-called risk tables for calculating 
individual’s risk numbers. However, they are not widely used in routine practice and it is 
important to understand the conditions for their use.
Objectives: Systematic review of the literature on professionals’ performance regarding car-
diovascular risk tables, in order to develop effective implementation strategies.
Selection criteria: Studies were eligible for inclusion if they reported quantitative empiri-
cal data on the effect of professional, ﬁ  nancial, organizational or regulatory strategies on the 
implementation of cardiovascular risk tables. Participants were physicians or nurses.
Outcome measure: Primary: professionals’ self-reported performance related to actual use 
of cardiovascular risk tables. Secondary: patients’ cardiovascular risk reduction.
Data collection and analysis: An extensive strategy was used to search MEDLINE, EMBASE, 
CINAHL, and PSYCHINFO from database inception to February 2007.
Main results: The review included 9 studies, covering 3 types of implementation strategies 
(or combinations). Reported effects were moderate, sometimes conﬂ  icting and contradictory. 
Although no clear relation was observed between a particular type of strategy and success or 
failure of the implementation, promising strategies for patient selection and risk assessment 
seem to be teamwork, nurse led-clinics and integrated IT support.
Conclusions: Implementation strategies for cardiovascular risk tables have been sparsely stud-
ied. Future research on implementation of cardiovascular risk tables needs better embedding in 
the systematic and problem-based approaches developed in implementation science.
Keywords: systematic review, implementation, cardiovascular diseases, primary prevention
Introduction
Reducing levels of modiﬁ  able cardiovascular risk factors is a key goal in the prevention 
of cardiovascular diseases (CVD), and guidelines are an important means of achiev-
ing this goal (Graham et al 2006). Primary preventive treatment is targeted at patients 
who are asymptomatic but are at elevated absolute 10-year CVD risk. Identiﬁ  cation 
of persons at high risk is guided by so-called risk tables, which are tools designed for 
the assessment of an individual’s risk score. Numerous CVD-risk tables are avail-
able (Sheridan et al 2003; Will 2005). Risk tables differ in many respects, eg, in the 
way risks are framed and presented, the number of risk factors included, outcome 
measures, interpretation, and indications for medical treatment (Thomas et al 1999; 
Conroy et al 2003; Sheridan et al 2003). These differences, and the validity of the 
prediction function, are still subjects of study and debate (Brindle et al 2006; Graham 
et al 2006; Wang et al 2006).
Despite certain weaknesses or restrictions, there is no doubt about the value of risk 
tables for preventive treatment in everyday patient care. However, extensive efforts 
to publish and disseminate such tables have not yet resulted in the desired level of Vascular Health and Risk Management 2008:4(3) 536
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implementation in routine practice (De Koning et al 2004). 
A systematic review of the effectiveness of cardiovascular 
risk tables as regards risk reduction in daily practice was 
inconclusive in terms of the effect on patients’ risk reduction, 
because application of the risk tables by the professionals was 
not optimal. It became clear that a serious implementation 
problem needed to be addressed. The poor uptake of risk 
tables by the physicians was conﬁ  rmed in observational stud-
ies (Brindle et al 2006). A risk calculator for risk management 
was only routinely used by 17% of American family physi-
cians (Eaton et al 2006), and less than half of the physicians in 
two European studies (De Muylder et al 2004; Graham et al 
2006). Moreover, Australian GPs reported that – if they used 
cardiovascular risk assessment tools at all – they used them 
in a restricted manner, only as an aid to patient education 
(Torley et al 2005). Apparently, there is a gap between the 
high risk approach advocated in the prevention of CVD and 
the actual use of risk tables in routine practice. A high-risk 
approach supported by risk tables seems to be an innovation 
that is not easy to implement. It is important to investigate 
what implementation strategies are most effective to ensure 
a good uptake of the risk tables in normal practice.
The literature reports on many different methods, 
strategies, and measures to introduce innovations, guide-
lines, best practices, or new procedures into clinical 
practice (Grimshaw 2003). Effective implementation of 
innovations seems to be more successful with strategies 
for implementation that are tailored to the speciﬁ  c goals, 
target group and setting (Grol 1997, 2001, 2003; Shaw 
2005). Therefore, the objective of our study was to sys-
tematically review the literature on health professionals’ 
performance with respect to cardiovascular risk tables, in 
order to search for implementation strategies that enable 
professionals to use cardiovascular risk tables effectively 
in the prevention of CVD.
Methods
Design
Systematic literature review.
Studies included
A study was eligible for inclusion in the review if it met the 
following inclusion criteria:
•  quantitative empirical data were reported;
•  a professional, ﬁ  nancial, organizational, or regulatory 
strategy was used to implement a CVD-risk table 
(Table 1);
•  participants were physicians or nurses;
•  the primary outcome measure was professionals’ 
performance regarding the actual use of cardiovascular 
risk tables, and the secondary outcome measure was 
patients’ cardiovascular risk reduction by improving 
one or more modiﬁ  able risk factors, eg, blood pressure, 
cholesterol, smoking, etc.
No restrictions were used as regards setting.
Search strategy
We elaborated on the extensive search strategy used by 
Brindle and colleagues (2006), who recently reviewed the 
accuracy and impact of risk assessment in the primary preven-
tion of CVD. We added free-text search terms related to the 
implementation of cardiovascular risk tables. Table 2 details 
the terms used to search MEDLINE. Appropriate adaptations 
of the search syntax were made when searching EMBASE, 
CINAHL, and PSYCHINFO. We covered the period from 
database inception to February 2007. Reference lists of 
included articles were scanned to identify additional study 
reports. Languages were restricted to Dutch, English, and 
German.
Data extraction
Titles and abstracts of all retrieved references were scanned 
by one author (BvS), after which two reviewers (BvS 
and TvdW) independently assessed the remaining set of 
articles for deﬁ  nitive inclusion or exclusion. The ﬁ  nal set of 
included studies was assessed by one of the authors (BvS) 
on the basis of the following methodological aspects; study 
design, type of intervention, participants (profession), setting 
(location of care and country), and methods (unit of allocation 
and quality criteria); his ﬁ  ndings were checked by another 
author (TvdW). The ﬁ  nal decisions on inclusion and data 
extraction per study were made by consensus.
Data analysis
The examination of the methodological quality of the studies 
was guided by the Data Collection Template (July 2002) of 
The Cochrane Effective Practice and Organisation of Care 
(EPOC) group, see www.epoc.uottawa.ca/tools.htm.
Results
Over 1800 titles and abstracts were scanned, and the full text 
of 37 articles was assessed. Ten of these articles (2 articles 
reporting on the same study) met our inclusion criteria, 
resulting in 9 studies being included. The included studies were 
categorized according to their main type of intervention(s) in 
EPOC terms. These are summarized in Table 3A–C.Vascular Health and Risk Management 2008:4(3) 537
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Participants and setting
Nearly all participants in the included studies were medical doc-
tors, either general practitioners or internal medicine residents, 
while 3 studies involved practice nurses or practice assistants 
in the implementation strategy. The location of care included 
hospital outpatient clinics in the UK and the USA (Hall et al 
2003; Jacobson et al 2006) and GP surgeries in Norway, the 
UK, the Netherlands, and New Zealand (Hetlevik et al 1999; 
Peters et al 1999; Montgomery et al 2000; Fretheim et al 2006b; 
Sinclair and Kerr 2006; Van Steenkiste et al 2007).
Characteristics of the studies
The trials differed considerably in size: the smallest trial 
included 323 patients, while a bigger trial included 2239 
patients. In this large study, however, the risk table was 
only applied to 12% (N = 104) of the eligible patients 
(Hetlevik et al 2000). In the majority of the studies, the propor-
tion of patients who completed the proposed study protocol 
was small. One trial included no patients, but 343 GPs were 
asked to evaluate the intervention strategy (De Muylder et al 
2005). This trial, as well as 5 other studies, may have suffered 
from a unit of allocation problem, particularly, a difference 
between the unit of allocation and the unit of analysis, without 
controlling for this by means of clustered data analysis.
Seven randomized controlled trials (RCT) were found, 
one of them a prospective RCT without follow-up (Hall et al 
2003), the others varying in time until follow-up assessment 
from 6 to 18 months (Hetlevik et al 1999; Montgomery 
et al 2000; Jacobson et al 2006; Fretheim et al 2006b). One 
study reported on blinded assessment of the primary out-
comes (Fretheim et al 2006b), while 5 studies mentioned 
concealment of intervention allocation. Primary outcomes 
Table 1 Types of intervention, listed according to EPOCa
Professional interventions Financial interventions Organizational interventions Regulatory interventions
Distribution of educational materials Provider interventions Provider oriented interventions Changes in medical liability
Educational meetings. Fee-for-service Revision of professional roles Management of patient complaints
Local consensus processes Prepaid Clinical multidisciplinary teams Peer review
Educational outreach visits Capitation Formal integration of services Licensure
Local opinion leaders Provider salaried service Skill mix changes
Patient-mediated interventions Prospective payment Continuity of care
Audit and feedback Provider incentives Arrangements for follow-up
(Computerized) reminders
Marketing
Mass media
Institution incentives
Provider grant/allowance
Institution grant/allowance
Provider penalty
Institution penalty
Formulary
Patient interventions
Premium
Co-payment
User-free
Patient incentives
Patient grant/allowance
Patient penalty
Case management (including co-
ordination of assessment, treatment 
and arrangements for referrals).
Satisfaction of providers with the con-
ditions of work and the material and 
psychological rewards
Communication and case discussion 
between distant health professionals
Patient oriented interventions
Mail order pharmacies
Presence and functioning of adequate 
mechanisms for dealing with patients’ 
suggestions and complaints.
Consumer participation in governance 
of health care organizations
Structural interventions
Changes to the setting/site of service 
delivery
Changes in physical structure, facilities 
and equipment
Changes in medical record systems
Changes in scope and nature of ben-
eﬁ  ts and services.
Presence and organization of quality 
monitoring mechanisms.
Ownership, accreditation, and afﬁ  liation 
status of hospitals and other facilities.
Staff organization
Notes: aOther categories to be agreed in consultation with the EPOC editorial team.Vascular Health and Risk Management 2008:4(3) 538
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Table 2 Medline search terms and strategy
Basic search strategy (Brindle)
#1 chd risk assessment$ #37 risk calculation$ #72 (busselton adj2 score$)
#2 cvd risk assessment$ #38 risk calculator$ #73 erica risk score$
#3 heart disease risk assessment$ #39 risk factor$ calculator$ #74 framingham scor$
#4 coronary disease risk assessment$ #40 risk factor$ calculation$ #75 dundee scor$
#5 cardiovascular disease risk assessment$ #41 risk engine$ #76 brhs scor$
#6 cardiovascular risk assessment$ #42 risk equation$ #77 British Regional Heart study risk scor$
#7 cv risk assessment$ #43 risk table$ #78 brhs risk scor$
#8 cardiovascular disease$ risk assessment$ #44 risk threshold$ #79 dundee risk scor$
#9 coronary risk assessment$ #45 risk disc? #80 framingham guideline$
#10 coronary risk scor$ #46 risk disk? #81 framingham risk?
#11 heart disease risk scor$ #47 risk scoring method? #82 new zealand table$
#12 chd risk scor$ #48 scoring scheme? #83 ncep guideline?
#13 cardiovascular risk scor$ #49 risk scoring system? #84 smac guideline?
#14 cardiovascular disease$ risk scor$ #50 risk prediction? #85 copenhagen risk?
#15 cvd risk scor$ #51 predictive instrument? #86 or/57–85
#16 cv risk scor$ #52 project$ risk? #87 56 or 86
#17 or/1–16 #53 cdss #88 exp decision support techniques/
#18 cardiovascular diseases/ #54 or/28–53 #89 Diagnosis, Computer-Assisted/
#19 coronary disease/ #55 27 and 54 #90 Decision Support Systems, Clinical/
#20 cardiovascular disease$ #56 17 or 55 #91 algorithms/
#21 heart disease$ #57 new zealand chart$ #92 algorithm?
#22 coronary disease$ #58 shefﬁ  eld table$ #93 algorythm?
#23 cardiovascular risk? #59 procam #94 decision support?
#24 coronary risk? #60 General Rule to Enable Atheroma Treatment #95 predictive model?
#25 exp hypertension/ #61 dundee guideline$ #96 treatment decision?
#26 exp hyperlipidemia/ #62 shaper scor$ #97 scoring method$
#27 or/18–26 #63 (brhs adj3 score$) #98 (prediction$ adj3 method$)
#28 risk function #64 (brhs adj3 risk$) #99 or/88–98
#29 Risk Assessment/mt (Methods) #65 copenhagen risk #100 Risk Factors/
#30 risk functions #66 precard #101 exp Risk Assessment/
#31 risk equation$ #67 (framingham adj1 (function or functions)) #102 (risk? adj1 assess$)
#32 risk chart? #68 (framingham adj2 risk) #103 risk factor?
#33 (risk adj3 tool$) #69 framingham equation #104 or/100–103
#34 risk assessment function? #70 framingham model$ #105 27 and 99 and 104
#35 risk assessor #71 (busselton adj2 risk$) #106 87 or 105 (448.950)
#36 risk appraisal$
Adjustments for the current review 
#107 106 and quality* health care #116 115 and clin* trial  #129 128 and cardio* risk*
#108 106 and practice pattern* health care #117 115 and rand* trial #130 128 and risk tables
#109 106 and implement* strateg* #118 115 and randomised trial #131 128 and cardio* risk?
#110 106 and implement*  #119 115 and randomized trial #132 128 and risk manag*
#111 106 and dissemination  #120 115 and clinical trial
#112 106 and diffus*  #121 115 and cohort #133 115 and process assessment
#113 106 and guideline*  #121 115 and control* trial #134 115 and process evaluation
#114 106 and implementation? #122 115 and comparat* study #135 115 and #17
#115 107–114 (18607) #123 115 and random* control* trial
#124 115 and observat* study
#125 115 and rand* clin* trial
#126 115 and control* study
#127 115 and rand* study
#128 116–127Vascular Health and Risk Management 2008:4(3) 539
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relating to the health professionals were the recording of 
CV risk and risk factors, the ability to identify patients at high 
risk, and appropriate indications for treatment (prescribing of 
cardiovascular drugs). Secondary, patient-related outcomes 
concerned CV risk and risk reduction, blood pressure, serum 
cholesterol, body mass index, and self-reported lifestyle.
Type of intervention and effects
We found that the interventions in the included studies were 
basically limited to three types: professional strategies or 
combinations of them (without patient involvement); com-
binations of professional- and patient-mediated strategies; 
organizational strategies or combinations of professional 
and organizational strategies. In general, the effects of the 
interventions on primary outcomes were small, absent or 
contradictory for the same outcome.
Professional strategies
Education was the single intervention in one of the three 
‘professional-oriented’ trials. This was found to signiﬁ  cantly 
increase the use of the risk tables (De Muylder et al 2005). 
The other two studies involved one or more educational meet-
ings for transfer of knowledge, in combination with training 
in the use of a stand-alone computerized decision support sys-
tem (CDSS) (Hetlevik et al 1999; Montgomery et al 2000). In 
the 3-armed trial by Montgomery, the use of the CDSS plus a 
paper version of the risk tables, or a paper version only versus 
usual care, had no effect on the ability to identify patients at 
high cardiovascular risk or on more accurate use of the risk 
tables. Although increased prescribing of CV drugs and a 
signiﬁ  cantly lower systolic blood pressure was seen in the 
‘risk chart only’ group, no differences in risk reduction were 
found compared to usual care (Peters et al 1999; Montgomery 
et al 2000). Interventions in which the educational meetings 
and the use of a CDSS were supplemented with educational 
materials, follow-up telephone calls and feedback on actual 
performance had no effect on the recording of risk factors, 
cholesterol level, BMI, or CV risk. However, a signiﬁ  cant 
mean reduction in diastolic blood pressure (1 mm HG) was 
reported (Hetlevik et al 1999).
Professional- and patient-mediated strategies
Two trials combined professional interventions, such as 
education plus audit and feedback, with a patient-mediated 
intervention, involving new information on patients’ CV 
risk being made available at the consultation (Fretheim 
et al 2006b), and introducing a decision aid for patients 
(Van Steenkiste et al 2007). The trial by Fretheim and 
colleagues (2006b) used an outreach visit to educate GPs 
on CV prevention and risk communication, as well as to 
give feedback on actual performance, and train them to use 
a CDSS. The CDSS generated ‘pop-ups’ on screen whenever 
an elevated blood pressure or cholesterol level was recorded, 
had a CV-risk calculator, generated treatment advice, and 
could be used to print patient-education materials. It had no 
effect on CV-risk assessment prior to prescribing (Fretheim 
et al 2006b). The trial by Van Steenkiste and colleagues 
(2007) used a combination of a 4-hour training session in 
the use of the risk tables, risk communication, and a decision 
aid for patients, which was to be used in two consultations 
to ensure patient involvement in the second consultation. 
Neither resulted in improved performance of the GPs in 
terms of risk classiﬁ  cation, assessment, or management (Van 
Steenkiste et al 2007).
Organizational
The focus of the interventions in this group of 4 studies 
(2 of which were noncontrolled) was a change in facili-
ties and equipment. In one of the two controlled trials, 
patients’ CV risk was clearly indicated (by the researcher) 
on the front page of the patients’ ﬁ  le. This had no effect 
on prescribing behavior, treatment or referral, except that 
a signiﬁ  cant increase in the use of CV drugs was observed 
for the high-risk group (Hall et al 2003). The other con-
trolled trial involved adding an educational meeting of the 
professionals, and contrasted a low-detail educational form 
including CV risk on the patients’ ﬁ  le in the intervention 
group with a more detailed form without CV risk in the 
control group. This resulted in overuse of statins in the 
moderate-risk group and no effect in the high-risk group 
(Jacobson et al 2006).
One of the two noncontrolled studies evaluated a 
risk-calculating facility embedded in a lipid test ordering 
procedure. Statin prescribing was found to be improved 
after risk assessment, but only 14 GPs used the laboratory 
service involved in the study (Ford et al 2001). The other 
study used a CDSS with risk calculator, integrated in the 
practice management system, which linked pop-up alerts 
to pre-selected ﬁ  les that appeared whenever the patient ﬁ  le 
was opened. In addition, the eligible patients were sent a 
letter explaining the value of screening for CV risk and 
inviting them for a risk assessment. CV-risk assessment 
had increased from 4.7% to 53.5% one year after imple-
mentation of the system change. Screening rates were 
higher in practices where nurses were responsible for the 
screening.Vascular Health and Risk Management 2008:4(3) 543
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Discussion
The small number of studies that could be included in this 
systematic review shows that the development of effective 
strategies for the implementation of cardiovascular risk 
tables in primary prevention has been sparsely studied so far, 
and that our understanding of ways to speed up the uptake 
of such new tools remains limited. The most common type 
of strategy was organizational, involving methods like pre-
senting CV risk on the front page of patients’ ﬁ  les or as a 
laboratory facility, and pro-active screening by pop-up alerts 
on the computer screen with invitations sent to patients’ 
homes for risk assessment. Patient-mediated implementation 
strategies have hardly been studied. Although no clear rela-
tion between a particular type of strategy and the success or 
failure of implementation was observed, promising strategies 
seemed to be those involving teamwork, nurse-led clinics 
and integrated IT support.
This review used a sensitive search, with language 
restricted to Dutch, English, and German publications. 
Although a restriction to randomized controlled trials is often 
desirable in systematic literature reviews, as it yields stud-
ies with the highest level of evidence, we chose to include 
non-controlled and quasi-controlled intervention studies as 
well, because of the expected low number.
Most of the studies we found do not seem to be theory-
driven or problem-driven (ie, tailored to barriers and 
facilitators), although in two studies, the strategy was guided 
by a systematic survey of barriers and facilitators before 
implementation was started (Fretheim et al 2006b; Van 
Steenkiste et al 2007). Despite this, no effects were found 
in these studies. Apart from a qualitative process evaluation, 
there is a need for more in-depth qualitative methods, eg, in-
depth interviews or focus groups with health professionals, 
to increase our understanding of this lack of effect (Fretheim 
et al 2006a). Ideally, this should be done along the lines of 
established planning models for implementation processes. It 
seems that insufﬁ  cient attention has been given to the various 
phases in the process of change for care providers and teams 
(Grol and Grimshaw 2003; Grol and Wensing 2004).
Although the theories and models on organizational 
determinants of innovation of care processes overlap, and the 
empirical evidence behind their assumptions about human 
behavior or organizational change is limited, we tried to apply 
our ﬁ  ndings to some of the many available theories. The 
Theory on Innovative Organizations tells us to take the type 
of organization into account. Decentralized decision making 
about innovations is crucial and good teamwork is one of 
the main keys for successful change. Process Reengineering 
Theory advises to focus on multidisciplinary care processes 
and collaboration instead of individual decision making. 
The theory aims to analyze and redesign the work process 
related to CVD prevention. The lessons learnt from this 
review, such as task delegation to a practice nurse and send-
ing invitational letters to patients for screening, could be part 
of it. Theories on Organizational Culture stress that changes 
in the culture can stimulate changes in performance; more 
teamwork, ﬂ  exibility and external orientation. Organizational 
Learning Theory advises to create conditions within the 
(practice) organization for continuous learning at all levels 
(Grol et al 2007).
Although ﬁ  nancial incentives are an effective way of 
changing professional behavior, none of the studies we 
found used a ﬁ  nancial incentive for the implementation 
of risk tables. It might be a powerful strategy, since most 
professionals might in the near future encounter ﬁ  nancial 
incentives that are linked to the quality of care, as is already 
customary in the UK. Many indicators of the Quality and 
Outcomes Framework are related to prevention of CVD. It 
appears that signiﬁ  cant health gains could result from achiev-
ing these quality targets (McElduff et al 2004; Roland 2004; 
Sutton and McLean 2006; Campbell et al 2007).
Ideally, implementation strategies should be tailored to 
support physicians’ needs, and as such should be based on 
the problems they are actually facing (Grol and Grimshaw 
2003; Grol and Wensing 2004). We distinguished 5 needs 
related to CVD prevention, and propose recommendations 
for implementation based on the review:
1.  Supporting physicians in the process of case-ﬁ  nding of 
potential high-risk patients. This is an essential step in 
successful application of the risk tables. Active support 
can be provided by pop-up alerts linked to pre-selected 
ﬁ  les that appear whenever a patient ﬁ  le is opened. Letters 
sent to patients’ homes, explaining the value of screening 
for CV risk and with an invitation for risk assessment, 
can further improve screening rates, especially in those 
practices with an established culture of practice-nurse 
led clinics and teamwork between the practice nurses 
and the GPs.
2.  Supporting physicians in completing the risk proﬁ  le. A 
CDSS proved to be effective only when the decision sup-
port system was integrated in the practice management 
system.
3.  Supporting physicians in calculating the risk. Most 
of the studies promoted the use of a risk table, either 
paper-based or computerized, for risk calculation. The 
main problem seemed to be the actual use of the risk Vascular Health and Risk Management 2008:4(3) 544
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calculation tools, which many of the physicians failed 
to do. Initially, it was suggested that risk tables would 
be useful for clinicians to help them master concepts 
relating to CHD prevention, ie, as a kind of educational 
tool rather than a practice instrument for risk calcula-
tion and management (Jackson and Beaglehole 1995). 
Since nurses are likely to be the future consumers (Will 
2005), GPs could be supported by nurses in this task. 
Presenting the actual risk to the GPs, eg, by indicat-
ing the risk on the front page of patients’ ﬁ  les, only 
had a minor effect on physicians’ behavior in terms of 
prescribing CV drugs. Nevertheless, confronting GPs 
with their patients’ actual risk may have corrected their 
misperceptions and could as such help to generate a bet-
ter performance, as misperception of cardiovascular risk 
is not uncommon among health professionals (Peters 
et al 1999; De Muylder et al 2004; Frijling et al 2004; 
Mosca et al 2005; Graham et al 2006; Van der Weijden 
et al 2007).
4.  Supporting physicians in risk communication. Once 
the risk has been calculated the next challenge is how 
to present it in an effective way. Most patients have a 
hard time understanding CVD risks (Erhardt and Hobbs 
2002; Van Steenkiste et al 2004). Perception of risks 
tends to be inaccurate and people ﬁ  nd it difﬁ  cult to 
handle risks (Elwyn et al 2001). The format (framing) 
in which risk information is presented affects people’s 
perception of risks and decision-making (Timmermans 
et al 2004). For example, framing in relative risk or 
loss framing are more persuasive compared to fram-
ing in absolute risk or gain framing respectively. This 
is reported for doctors (Rakow 2001), and patients 
(Edwards et al 2001; Feldman Stewart et al 2000; 
Lipkus et al 2001). Risk communication should include 
weighing up of risks and beneﬁ  ts of a treatment choice, 
and address the patient’s perception of probability of an 
event as well as the value of the event for that individual 
(Edwards et al 2001). To achieve this, health profes-
sionals need training to increase their competences in 
risk communication.
5.  Supporting physicians in deciding, jointly with the 
patient, on appropriate action for management. The 
use of a computerized decision support system to help 
physicians decide on appropriate management may result 
in some small favorable effects on prescribing behavior 
and blood pressure. So far, involving patients in the 
decision on appropriate management with the help of 
educational materials (including the risk table) has had 
no effect. Although patient involvement seems to be an 
effective prevention strategy, it is still unclear how this 
can be achieved (Edwards and Elwyn 1999; Edwards 
et al 2003). A successful strategy might be to delegate 
this task to a nurse or health coach, who has more time to 
explain CV risk and for patient involvement in decisions 
on management and follow-up (Vale et al 2003; Sol et al 
2005; Edelman et al 2006). Such a strategy is a subject of 
research in the current IMPALA trial (ISRCTN51556722), 
in which a risk communication tool and a decision aid 
are issued to patients for preparation at home, and in 
which the practice nurse applies an adapted motivational 
interviewing technique to discuss the risk and options for 
risk reduction (see www.trialregister.nl).
Conclusion
Effective primary prevention of cardiovascular diseases is 
not easy, and research on effective strategies for the imple-
mentation of risk tables has been sparse. Nevertheless, good 
teamwork, nurse-led clinics, and smart software programs, 
integrated in the practice management system, seem to be 
promising strategies for patient selection and risk assessment. 
Achieving patient involvement, a precondition for successful 
CV-risk management, is a challenge for future research that, 
together with the development of other professional- and 
organization-implementation strategies, needs to be embed-
ded in the methodology of implementation science.
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